Our intended operations in Kelowna, BC, Canada, will be based on a production environment that is more controlled and directed than a typical growing operation.

Canadian Operations: End-product Processing

  • We focus on strain development and end-product processing in Canada. Large scale production will occur in South America
  • Advantage for quality assurance and process control
  • Located in the region leading the globe in strain development and production knowledge (British Columbia)
  • Ability to produce as “Canadian Made” with source materials produced internationally
  • GMP design and procedures

Allied plans to purchase two 1.2-acre lots in Kelowna, BC, Canada, that are industrial zoned and pre-approved for the production of medical cannabis.

Within this controlled environment, we can custom breed certain cannabis strains to have the unique cannabinoid and terpene profile that is best suited to address today’s health issues with precision and efficacy.

In addition to the the Standard Licensed production facility, we can scale up to over 50,000 square feet with the two levels.

Both licenses are at the confirmation of readiness stage of Health Canada’s application process.

Click to view larger images.

Sign up to our newsletter and get first access to the latest investor news, events, and other important information related to Allied Health.

Keep Informed